首页> 外文期刊>Pilot and Feasibility Studies >Promoting adherence to treatment for latent TB infection through mobile phone text messaging: study protocol for a pilot randomized controlled trial
【24h】

Promoting adherence to treatment for latent TB infection through mobile phone text messaging: study protocol for a pilot randomized controlled trial

机译:通过手机短信促进对潜伏性结核感染治疗的依从性:一项针对随机对照试验的研究方案

获取原文
           

摘要

An estimated two billion people, over one third of the world’s population, have latent infection with Mycobacterium tuberculosis (LTBI). Patient adherence to LTBI treatment is currently poor given that individuals show no symptoms of illness and may not feel that they are at risk of developing active tuberculosis (TB). Short text messages can serve as a simple reminder to take medications and address barriers to adherence such as forgetfulness and lack of social support.Methods/designWe aim to determine the feasibility and acceptability of text reminders for improving adherence in latent TB patients using a randomized controlled single-blinded trial, measuring adherence through an increase in treatment completion rates. Forty adult LTBI participants will be randomized to either text messages plus phone call reminders or phone call reminders only (usual care). Recruitment, retention, and study acceptability will be assessed as primary outcomes.DiscussionThis pilot study will examine the feasibility of using text messaging for increasing adherence to treatment for latent tuberculosis infection. The study will allow for evaluation of process measures and challenges and development of a model for scaling up an effectiveness trial for increasing treatment adherence.Trial registration NCT02690818 (Clinical Trials.gov).
机译:估计有20亿人(全球人口的三分之一以上)潜伏感染了结核分枝杆菌(LTBI)。当前患者对LTBI治疗的依从性较差,原因是患者没有任何疾病症状并且可能不会感到自己患上活动性结核病(TB)。短信可以简单提醒人们服用药物并解决依从性障碍,例如健忘和缺乏社会支持。方法/设计我们旨在通过随机对照来确定文本提示在潜在结核病患者中改善依从性的可行性和可接受性单盲试验,通过提高治疗完成率来衡量依从性。 40名成年LTBI参加者将被随机分为短信,电话提醒或仅电话提醒(常规护理)。招募,保留和研究的可接受性将作为主要结局进行评估。讨论此初步研究将研究使用短信传递以增加对潜伏性结核感染治疗的依从性的可行性。该研究将评估过​​程措施和挑战,并开发模型以扩大有效性试验以增加治疗依从性。试验注册号NCT02690818(Clinical Trials.gov)。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号